Directed Differentiation of Dopaminergic Neuronal Subtypes from Human Embryonic Stem Cells
Overview
Reproductive Medicine
Authors
Affiliations
How dopamine (DA) neuronal subtypes are specified remains unknown. In this study we show a robust generation of functional DA neurons from human embryonic stem cells (hESCs) through a specific sequence of application of fibroblast growth factor 8 (FGF8) and sonic hedgehog (SHH). Treatment of hESC-derived Sox1+ neuroepithelial cells with FGF8 and SHH resulted in production of tyrosine hydroxylase (TH)-positive neurons that were mostly bipolar cells, coexpression with gamma-aminobutyric acid, and lack of midbrain marker engrailed 1 (En1) expression. However, FGF8 treatment of precursor cells before Sox1 expression led to the generation of a similar proportion of TH+ neurons characteristic of midbrain projection DA neurons with large cell bodies and complex processes and coexpression of En1. This suggests that one mechanism of generating neuronal subtypes is temporal availability of morphogens to a specific group of precursors. The in vitro-generated DA neurons were electrophysiologically active and released DA in an activity-dependent manner. They may thus provide a renewable source of functional human DA neurons for drug screening and development of sustainable therapeutics for disorders affecting the DA system.
Advancing Glioblastoma Research with Innovative Brain Organoid-Based Models.
Correia C, Calado S, Matos A, Esteves F, De Sousa-Coelho A, Campinho M Cells. 2025; 14(4).
PMID: 39996764 PMC: 11854129. DOI: 10.3390/cells14040292.
In vitro human cell culture models in a bench-to-bedside approach to epilepsy.
Danacikova S, Straka B, Danek J, Korinek V, Otahal J Epilepsia Open. 2024; 9(3):865-890.
PMID: 38637998 PMC: 11145627. DOI: 10.1002/epi4.12941.
Lopez-Ornelas A, Escobedo-Avila I, Ramirez-Garcia G, Lara-Rodarte R, Melendez-Ramirez C, Urrieta-Chavez B Cells. 2023; 12(23).
PMID: 38067166 PMC: 10706241. DOI: 10.3390/cells12232738.
Challenges involved in cell therapy for Parkinson's disease using human pluripotent stem cells.
Moon H, Kim B, Kwon I, Oh Y Front Cell Dev Biol. 2023; 11:1288168.
PMID: 37886394 PMC: 10598731. DOI: 10.3389/fcell.2023.1288168.
Rather H, Almousa S, Craft S, Deep G Ageing Res Rev. 2023; 92:102088.
PMID: 37827304 PMC: 10842260. DOI: 10.1016/j.arr.2023.102088.